Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1061 publications
First-line treatment of elderly patients with CLL: An innovative, chemo-free approach
Journal: Deutsche medizinische Wochenschrift (1946)
Published: October 10, 2025
The Impact of Biosimilar Adoption on Drug Utilization and Cost in Chemotherapy-A Single Center Retrospective Study
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: October 06, 2025
Obinutuzumab for the treatment of active lupus nephritis
Journal: Innere Medizin (Heidelberg, Germany)
Published: September 09, 2025
Persistent Respiratory Symptoms Post-COVID-19 in a Non-Hodgkin Lymphoma Patient: A Case Report.
Journal: Cureus
Published: September 09, 2025
Obinutuzumab, an Anti-CD20, in Refractory Adult Autoimmune Podocytopathies: Report of 2 Cases.
Journal: Kidney medicine
Published: August 21, 2025
Obinutuzumab for PLA2R-associated membranous nephropathy.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: August 20, 2025
Real-world safety and tolerability of rapid infusion obinutuzumab in chronic lymphocytic leukemia, small lymphocytic lymphoma and non-Hodgkin lymphoma: a provincial review.
Journal: Haematologica
Published: August 10, 2025
Venetoclax and obinutuzumab in first-line treatment of unfit patients with CLL - real-life data analysis of the Polish Adult leukemia group.
Journal: Leukemia & lymphoma
Published: August 01, 2025
Indirect Comparisons of the Efficacy and Safety of Zanubrutinib versus Venetoclax plus Obinutuzumab in Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Journal: Oncology and therapy
Published: July 29, 2025
Triplet Therapies in Chronic Lymphocytic Leukemia.
Journal: Hematology/oncology clinics of North America
Published: July 24, 2025
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis.
Journal: The New England journal of medicine
Published: July 23, 2025
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis.
Journal: The New England journal of medicine
Published: July 23, 2025
Last Updated: 10/31/2025